Schreiber R, Crane K, Patel J. Efficacy and Tolerability of Tazarotene Foam 0.1% Across Age, Gender, and Race: An Integrated Review of Two Phase III Trials. J of Skin [Internet]. 2017Oct.27 [cited 2024Sep.20];1(3.1):s50. Available from: https://dermsquared.com/skin/article/view/176